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2Abstract
Background: The determinants of guideline panels’ recommendations remain 
uncertain. 
Objective:  To investigate factors considered by members of 8 panels convened by the 
American Society of Hematology (ASH) to develop guidelines using GRADE system.
Study Design and Setting: web-based survey of the participants in the ASH guidelines 
panels.  Analysis: two level hierarchical, random-effect, multivariable regression 
analysis to explore the relation between GRADE and non-GRADE factors and strength 
of recommendations (SOR).
Results:  In the primary analysis, certainty in evidence [OR=1.83; (95CI% 1.45 to 
2.31)], balance of benefits and harms [OR=1.49 (95CI% 1.30 to 1.69)] and variability in 
patients’ values and preferences [OR=1.47 (95CI% 1.15 to 1.88)] proved the strongest 
predictors of SOR. In a secondary analysis, certainty of evidence was associated with a 
strong recommendation [OR=3.60 (95% CI 2.16 to 6.00)] when panel members 
recommended “for” interventions but not when they made recommendations “against” 
[OR=0.98 (95%CI: 0.57 to 1.8)] consistent with “yes” bias.   Agreement between 
individual members and the group in rating SOR varied (kappa ranged from -0.01 to 
0.64). 
Conclusion: GRADE’s conceptual framework proved, in general, highly associated with 
SOR.  Failure of certainty of evidence to be associated with SOR against an 
intervention, suggest the need for improvements in the process. 
Running title: guidelines panels’ decision-making
Keywords: Practice Guidelines, Clinical Recommendations, “Yes” bias, Decision 
Theory, Group Decision Making, GRADE 
3What is new?
Key findings: 
 The GRADE guidelines system specifies factors that guidelines panels should take into 
considerations when issuing recommendations. However, many other (non-GRADE) factors may 
also affect recommendations.
 To what extent GRADE vs. non-GRADE factors influence guidelines panels’ decision-making 
remains uncertain. 
 We found that GRADE factors affect guidelines decision-making process more than non-GRADE 
factors, likely due to the effect of instructions provided within structured GRADE Evidence-to-
Decision (EtD) framework. Consistent with principles of evidence-based medicine, we confirmed 
relation between the certainty of evidence and strength of recommendations.
 The findings remained robust when panels issued recommendations for health interventions. 
However, when the panels generated recommendations against health interventions, the relation 
between certainty of evidence and strength of recommendations disappeared pointing to the 
existence of so called “yes” bias (people acquiesce to “yes” statements more readily than to “no” 
statements)
 Even within highly structured GRADE process, the panel members demonstrated variability in 
their individual responses (kappa between individual panel members and the group consensus 
vote for strength of recommendations ranged from very poor (-0.01) to moderate (0.64)), 
 Depending on the analytical model, some non-GRADE factors were also associated with the 
strength of recommendations issued by the panels. Different non-GRADE factors were 
associated with recommendations “for” vs. “against” health interventions.  However, age/clinical 
experience of the panelists remained statistically significant across all models.
What this adds to what is known: 
 This quantitative analysis of 8 panels confirms that GRADE instruction given within EtD structured 
framework results in consideration of GRADE factors as intended by the GRADE system. 
 The system does not, however, appear to give consistent results when the panels issue 
recommendation for vs against health intervention.
 In addition, individual member “assessment” often considerably differ from the group, consensus 
vote.
What is the implication, and what should change now: 
 Guideline panels that place a high value on adherence to the GRADE system should consider 
use of EtD framework in developing their recommendations.
 To avoid “yes” bias, guidelines developers should, in most instances, express all 
recommendations as a vote “for” instead of “against” recommendations 
 Exploration of reasons why panel members are sometimes in agreement and sometimes not may 
inform the need for additional strategies such as more extensive training in GRADE to reduce 
variability.
4Trustworthy evidence-based clinical practice guidelines (CPG)1-3 represent one 
approach to addressing suboptimal clinical decision making.4,5 6 7 In fact, measuring 
adherence to CPGs is one of the key approaches to quality improvement.7 8 
If CPGs are to improve health outcomes, they must be developed using rigorous 
methodological principles2 developed during the last 20 years through systems of rating 
the certainty of evidence and strength of recommendations. 9 10 11 12 13   Of these 
systems, the GRADE (Grading of Recommendations Assessment, Development, and 
Evaluation) approach represents the most transparent, rigorously developed and 
documented to date,14 2 which is endorsed by over 100 professional organizations, 
including the World Health Organization, the Cochrane Collaboration, and a number of 
leading American organizations.15
GRADE has identified a number of factors that CPG panels should consider when 
making recommendations, including the certainty of evidence, the balance between 
benefits and harms, patient values and preferences, resource and cost considerations, 
as well as issues related to acceptability, feasibility, and health equity.16,17  Although 
GRADE provides a normative system for how CPG panels ‘ought to’ develop guidelines, 
in what manner guideline panels actually make their judgments remains unclear. 
Despite the breadth of GRADE’s specified considerations, many additional factors 
not formally captured in the GRADE system may affect panel judgments. Broadly, these 
factors include18: a) decision features, or characteristics of the 
decision/recommendation (e.g., high stake vs. low-stake clinical recommendations, 
such as developing guidelines for vulnerable populations in a politically charged 
atmosphere), b)  situational/contextual factors (e.g., time pressure, cognitive load, role 
5in the panel as chair, methodologist, panelists, etc), and c) individual characteristics of 
the decision maker (e.g. age). 18-21 
How and to what extent these additional factors contribute to the decision-making 
process remains unclear. In addition, development of CPGs ultimately relies on the 
group judgment of the panel. Despite its importance, we know little about how the group 
consensus relates to the individual judgments of its members. We, therefore, designed 
a study addressing the interplay of group and individual processes in real life decision 
making and provide the first analysis of a guidelines panel’s decision process.
Methods
We studied the process in 8 panels convened by the American Society of 
Hematology (ASH) to develop guidelines for the management of the following 
conditions: heparin-induced thrombocytopenia (HIT); thrombophilia; venous 
thromboembolism (VTE) in pregnancy; VTE in pediatric populations; optimal 
management of anticoagulation therapy; VTE in patients with cancer; treatment of VTE; 
and management of immune thrombocytopenia (ITP). 
A series of webinars introduced panel members to the GRADE system. During a 
number of conference calls, the panel members defined and prioritized the clinical 
questions, guided a systematic review team in the collection and analysis of the relevant 
evidence, and in some cases discussed pre-voting results for guideline questions. All 
recommendations included judgments (weak or conditional vs strong) in favor of 
intervention (I) or comparator (C) for a given outcome (O) related to the population of 
interest (P).
6Each panel developed final recommendations through group consensus during 
face-to-face meetings using GRADE’s structured evidence-to-decision (EtD) 
framework.16,17 For each recommendation, the panel made explicit judgments for each 
factor in the framework; before doing so, panelists reviewed a summary of these 
judgments (see Appendix for the actual presentation framework).  Each panel member 
completed a survey detailing their judgments related to relevant GRADE factors and the 
final recommendations during the meeting or shortly thereafter.
We used frequencies and percentages to describe characteristics of panels and 
panel members participating in the development of the ASH guidelines.  We explored 
GRADE and non-GRADE factors that might influence the panels’ recommendations, all 
defined a priori as per current literature. 18-21 The GRADE factors included certainty of 
evidence supporting recommended intervention, balance between benefits and harms, 
assessment of variability or uncertainty in patients’ value and preferences, and 
resources that the panel judged may be needed to implement recommendations. 
Certainty of evidence was coded on a 1 to 4 scale, with 1 indicating very low certainty of 
evidence and 4 high certainty of evidence. Variability or uncertainty in patient’s values 
and preferences (V&P) was coded on a scale 1 to 4 (1=important, 2=possibly important, 
3=probably not important, 4=not important). Judgments on use of resource/costs were 
coded on a 5-point Likert scale (1=large costs,  2=moderate costs,  3=neither, 
4=moderate savings,  5=large savings). Judgments on the balance of intervention 
benefit/harms was coded on 5-point Likert scale (1=favors the comparison, 2=probably 
favors the comparison, 3=does not favor either, 4=probably favors the intervention; 
5=favors the intervention).  Each of these categorical variables was treated in the 
7analysis as continuous assuming the equivalent interval effects among the consecutive 
scores.
Although the panels, using the EtD framework, also considered issues of 
acceptability, feasibility, and health equity (see Appendix), limiting response burden on 
panelists precluded our considering these issues. 
Non-GRADE variables included:
a) individual characteristics of the decision maker: age, sex, experience, expertise 
and cognitive styles, i.e. propensities to favor one decision-making or reasoning 
approach over another.20 The latter was assessed by administration of instruments to 
measure objectivism, i.e., tendency to seek empirical information to support decision 
making; intolerance of uncertainty22; maximizing-satisficing, i.e., assessment of 
tendency for individual to employ reasoning processes that will lead to making a good 
vs. best possible decision23; propensity to engage in analytical, rational thinking vs 
experiential-intuitive thinking20,24; and tendency to experience regret about making a 
decision.21 These instruments have proved valid and applicable to assessment of 
physicians’ decision-making.20  
b) characteristics of the decision/recommendation: recommendations made for 
vulnerable populations (children, women, inner city, rural, ethnic minority, low-income), 
reports of feeling pressured to issue certain type of recommendations/to conform with 
the group due to the potentially politically sensitive nature of guideline 
recommendations.
c) situational/contextual factors related to a given guideline recommendation: 
individual panel member’s conflicts of interest, role in the panel (chair, methodologist, 
8patient representative, panel member). The Supplementary material provides details 
related to all variables and instruments.
We constructed a model relating these variables to the strength of 
recommendations as either strong, weak, or no recommendation. We repeated the 
analysis according to the direction of the recommendation (“for” vs. “against”), omitting 
questions in which panels did not make a recommendation.25,26 
We employed a two level hierarchical, mixed multivariable logistic and ordered 
regression analysis to account both for panel level factors and individual level factors. 
Thus, judgments of recommendations were clustered within panel members, and these 
were clustered within panels. 
To compare individual panel recommendations with the group consensus, we 
calculated the agreement (kappa statistics and correlations) between each individual 
panel member’s average judgment (weighted by the number of their responses) and the 
group consensus recommendation. To account both for sampling error and the 
variability among the panels, we pooled kappa statistics across all panels by meta-
analyzing it under a random-effects model.27 To estimate the random effects of the 
panels on the percentage of the total residual variance in each individual member’s 
voting pattern, we estimated intraclass correlations (ICCs) after running the two-level 
mixed effect logistic regressions. All calculations were performed using STATA, version 
1528, and verified in SAS, version 9.4, by a second investigator.
Results
Fig 1 presents an overview of the data collection process. Table 1 presents 
characteristics of the panels and panel members participating in the development of the 
9ASH guidelines.  Typical panelists were male hematologists around 50 years of age 
from the United States with approximately 20 years of clinical experience. 
The panel meetings occurred between November 2016 and August 2017 in 
Washington, D.C. and lasted between 15 and 26 hours across two days (median=10 
hours per day).
Of 21 variables potentially associated with the strength of recommendations, 3 
GRADE and 2 non-GRADE factors displayed statistically significant association at the 
conventional p<0.05 levels (Table 2). Panel members’ judgment of certainty of the 
evidence [OR=1.84 (95%CI 1.46 to 2.31)] proved the strongest predictor - the more 
confident the panel members were regarding the certainty of the evidence, the more 
inclined they were to issue strong recommendations. 
Other factors associated with strong recommendations included age (per decade) 
[OR=1.79 (95CI% 1.2 to 2.84)] (older panel members were more inclined to make 
strong recommendations), followed by balance of benefits and harms [OR=1.49 (95CI% 
1.30 to 1.69)] (when balance favors intervention, the panelists are more likely to issue a 
strong recommendation), the uncertainty or variability in patients’ V&P [OR=1.47 
(95CI% 1.15 to 1.88)] (the less uncertainty or variability, more likely the panel was to 
issue a strong recommendation), and intolerance of uncertainties [OR=0.57 (95CI% 
0.37 to 0.86] (more intolerance, less likely a strong recommendations). 
Table 3 showed the logistic regression analysis when the panel members issued 
recommendations “strong for” vs. “weak for” in favor of a given intervention.  In this 
analysis, judgement about balance between benefits and harms was associated with an 
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OR of 18.3 [95% CI 7.67 to 43.7] for recommendations in favor of the intervention.  The 
second strongest predictor was certainty of evidence [OR=3.61 (95%CI 2.17 to 6.01)]. 
When panels judged that certainty in evidence is high and benefits outweigh harms in 
favor of intervention over the comparator, the predicted probability of issuing strong 
recommendation in favor of the intervention exceeded 90% (Fig 2).
Assessment of patients’ values and preferences as well as consideration of 
costs/resources were also highly statistically significant but at a somewhat lower odds 
ratio (Table 3).  Methodologists, in comparison to panel chairs, were less likely to issue 
strong recommendations [OR=0.06 (95CI% 0.04 to 0.85)]. Three non-GRADE factors 
also show statistically significant or borderline significant associations (Table 3). As in 
the main analysis (Table 2), older panel members were more inclined to make strong 
recommendations [OR=2.6 (95% CI 0.99-7.93)]. More experienced panel members 
tended to issue weaker recommendations [OR=0.891 (95CI% 0.795 to 0.98)] (see 
Discussion), while the tendency to employ a maximizing cognitive style when faced with 
decision difficulties was associated with OR=2.14(95% CI .99-4.65) (Table 3).
Table 4 outlines the analysis when the panel members issued recommendations 
“strong against” vs. “weak against” health interventions (Fig 3).  In this analysis, only 
one formal GRADE factor (the importance of patients’ V&P) had an effect, while 5 non-
GRADE factors displayed statistically significant association. More experienced panel 
members, those with higher intolerance of uncertainty and those with propensity toward 
analytical thinking tended to issue weaker recommendations against the intervention. 
On other hand, being a methodologist, older, recused from voting due to a conflict of 
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interest, or issuing guidelines for a vulnerable population were associated with strong 
recommendation against intervention.
Agreement between individual panel members and the group regarding strength of 
recommendations (SOR) ranged from poor (kappa ranging from: -0.01 to 0.03; 2 
panels) to fair (kappa range: 0.21 to 0.47; 4 panels) to moderate (kappa=0.64; 1 panel) 
(Fig 4). Agreement of judgments related to voting “for” and “against” the intervention 
was somewhat better 0.37 (95%CI 0.16 to 0.58) and 0.42 (95%CI: 0.19 to 0.64) 
respectively (data not shown).
Finally, we calculated ICC to determine the extent of the overall variation in the 
response of the panel members. The results varied with the analyses: in the main 
analysis (Tables 2) we found negligible correlation between individual vote and the 
panel voting pattern (ICC=0.06) but in the analysis that omitted the recommendations in 
which the panel didn’t issue a recommendation determining the strength of association 
and direction of the vote, ICC was 0.50 in recommendations “for” and 0.48 in 
recommendations “against”.
Discussion
We report the first study evaluating the impact of the GRADE system, and non-
GRADE factors that could impact on guidelines panel members’ decision making. 
Overall, we showed that factors associated with GRADE’s conceptual framework were, 
in general, highly associated with SOR.  A secondary analysis suggested, however, that 
certainty of evidence may have little or no influence on SOR when a panel makes 
recommendations against an intervention.   We also detected statistical association 
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between SOR and non-GRADE factors but, aside from age/clinical experience, these 
varied across statistical models. 
The main findings likely reflect the effect of instructions29,30 due to use of the highly 
structured GRADE EtD framework.31  Adherence to structure is typically seen with high-
ability participants (such as expert panelists) who can follow instructions that require 
cognitive effort and supress the influence of other factors and prior beliefs.29,32 The 
findings extend the observations from our qualitative analysis33 that policy-makers and 
users of guidelines who apply GRADE methods may expect that the guideline panels 
will not only rely on GRADE factors but use the cognitive processes that facilitate 
decision making according to the (GRADE) instructions. Nevertheless, individual 
characteristics such as age, experience, intolerance of uncertainty, and propensity 
toward analytical thinking were also, in some models, associated with SOR. 
Theoretically, a type of a task and instructions can activate cognitive processes to align 
them toward accomplishing stated goals.34 For example, the importance of intolerance 
of uncertainty can be seen as a response to the underlying clinical uncertainties that 
activate analytical reasoning processes that prompted development of guidelines in the 
first place.35 
Our results regarding the importance of certainty of evidence is consistent with 
observations in two smaller studies.36,37  The results provide empirical verification of the 
key EBM normative principle regarding the relationship between the credibility of 
underlying evidence and willingness to endorse a health intervention1: when certainty of 
evidence is high, we can expect that most panelists will issue strong recommendations. 
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However, this relationship disappeared when the panel members “voted” “against” 
health intervention. Potential explanations for this finding include: 1)  the “yes/for” 
bias25,26,38-40: according to dual process theory of acquiescence people are overall 
slower to respond to “no” than to “yes”. “Yes” (“for”) responses tap into “feeling of 
rightness” heuristic that the answer is correct: is automatic, effortless (type 1 process), 
which is activated much faster than effortful (type 2 processes) associated with 
processing of “no” (“against”) responses. 38-40; 2) Voting “against” an intervention is 
cognitively more challenging because people need to mentally simulate the 
consequences of two contradictory assessments- certainty of evidence, which moves 
from very low to high in “positive” direction and strength of recommendation “against” 
the intervention, which goes in the opposite direction. This often occurs when cognitive 
resources are depleted41,42 as when people are tired and decision-making occurs in 
time-constraint settings, which characterize most human engagements including 
guidelines development process; 3) in a number of cases, the question was formulated 
as a “vote” against intervention without explicit description of a comparator, which may 
have introduced a reference class problem (i.e., when reference category is not well 
specified, people’s estimates are often incorrect)43,44; 4) GRADE paradigmatic situations 
that justify strong recommendations despite low certainty evidence, may have occurred 
more in recommendations “against” than “for” interventions.45 
As in all research, we cannot exclude the possibility that some associations we 
observed may be simply due to chance. For example, as in our earlier study,20 we 
detected that effect of age and experience went in the opposite direction, which we 
judged to be a spurious association. This occurred because in medicine, as in many 
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professions, age and experience are positively correlated (r=0.85 in this study) across 
individuals, making it difficult to isolate the unique influence of a given variable on the 
third variable. 
Our results also provide empirical support for the importance of managing conflict of 
interests46,47- the panel members who were required to recuse themselves, had they 
been allowed to vote, would have registered different views from those of their 
colleagues.  
The frequent low agreement between judgments of individual panel members’ and 
the group consensus related to SOR raises the possibility that the apparent consensus 
represents individual panel members’ conforming to the group48,49, particularly since 
more than 50% of discussion was dominated by chairs and co-chairs.33 In a classic 
paper on opinions and social pressure, Asch warned that “Consensus is an 
indispensable condition in a complex society, but consensus, to be productive, requires 
that each individual contribute independently out of experience and insight. When 
consensus is produced by conformity, the social process is polluted”. 48 
Nevertheless, fewer than 2% of participants (Table 2) reported that they felt any 
pressure to conform to the group vote. Earlier studies suggested that when instructions 
that clearly operationalize procedures are provided, agreement on assessments such 
as the certainty of evidence becomes high.50  Lack of familiarity with the GRADE system 
(despite introductory lectures about GRADE) and the complexity of the judgement 
inherent in making recommendations may explain the low agreement we observed. An 
alternative explanation is that many of the decisions were close calls in the panels 
where agreement was low – and fewer when agreement was high.  
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Another explanation for low agreement arises from our observation that variability in 
V&P was associated with SOR despite, as we have reported previously, only 1% of the 
discussion was devoted to this issue33.  It is possible that panelists had different views 
of the extent of diversity and uncertainty in V&P, views that they did not express in 
group discussion.  This suggests that chairs of guideline using GRADE should insist on 
repeated discussion of V&Ps issues. 
Strengths and Limitations
A strength of our study is that it is the first to assess the decision making of 
guidelines panels in natural, real-life setting.  At the same time, the observational design 
precluded experimental control of the variables that may allow drawing stronger 
inferences. Hence, future studies will be necessary to establish the generalizability of 
our findings. Nevertheless, our findings represent first initial insights into how guideline 
decision-making works in real life, and suggests possible improvements in the process
In conclusion, we found that policy-makers and users of guidelines who apply 
GRADE methods may expect that the guideline panels will rely on GRADE factors. 
However, low agreement between individual panel members and group consensus 
suggests that the process can be improved, perhaps by further operationalization of 
GRADE criteria, by better training of the panel members in GRADE methodology, and 
by framing, as far as is possible, all recommendations in terms of voting “for” instead of 
“against” a given health intervention. 
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Legend:
Fig 1 Overview of data collection process. Data were collected from the guidelines 
panels convened by The American Society of Hematology (ASH) to develop guidelines 
for the management of the following conditions: (a) prevention of venous thrombo-
embolism (VTE) in surgical hospitalized patients, (b) prevention of VTE in medical 
patients, (c) heparin-induced thrombocytopenia (HIT), (d) management of 
thrombophilia, (e) VTE in the context of pregnancy, (f) VTE in pediatric populations, (g) 
optimal management of anticoagulation therapy, (h) VTE in patients with cancer, (i) 
treatment of VTE, and (j) management of immune thrombocytopenia (ITP). 
Unfortunately, data collection from two panels were not recorded due to technical 
glitches. The final analysis included data from 8 panels (see text) 
Fig 2. Effect of certainty of evidence and judgments about the balance of benefits and 
harms (in favor of intervention over comparator). The vertical line around the each point 
denotes a 95% confidence interval.
Fig 3. A relationship between the quality (certainty) of underlying evidence and the 
probability of issuing of a strong recommendation FOR (a) vs. AGAINST (b) a given 
health intervention. The vertical line around each point denotes a 95% confidence 
interval. The results remained the same even though panelists were instructed to align 
strength of recommendations with direction of recommendations (the reminders were 
originally issued orally, but it was included in the survey for the last 5 panels) 
Fig 4. Agreement in judgements related to strength of recommendations between 
individual panel members and the group judgements
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What is new?
Key findings: 
 The GRADE guidelines system specifies factors that guidelines panels should take into 
considerations when issuing recommendations. However, many other (non-GRADE) factors may 
also affect recommendations.
 To what extent GRADE vs. non-GRADE factors influence guidelines panels’ decision-making 
remains uncertain. 
 We found that GRADE factors affect guidelines decision-making process more than non-GRADE 
factors, likely due to the effect of instructions provided within structured GRADE Evidence-to-
Decision (EtD) framework. Consistent with principles of evidence-based medicine, we confirmed 
relation between the certainty of evidence and strength of recommendations.
 The findings remained robust when panels issued recommendations for health interventions. 
However, when the panels generated recommendations against health interventions, the 
relation between certainty of evidence and strength of recommendations disappeared pointing 
to the existence of so called “yes” bias (people acquiesce to “yes” statements more readily than 
to “no” statements)
 Even within highly structured GRADE process, the panel members demonstrated variability in 
their individual responses (kappa between individual panel members and the group consensus 
vote for strength of recommendations ranged from very poor (-0.01) to moderate (0.64)), 
 Depending on the analytical model, some non-GRADE factors were also associated with the 
strength of recommendations issued by the panels. Different non-GRADE factors were 
associated with recommendations “for” vs. “against” health interventions.  However, 
age/clinical experience of the panelists remained statistically significant across all models.
What this adds to what is known: 
 This quantitative analysis of 8 panels confirms that GRADE instruction given within EtD 
structured framework results in consideration of GRADE factors as intended by the GRADE 
system. 
 The system does not, however, appear to give consistent results when the panels issue 
recommendation for vs against health intervention.
 In addition, individual member “assessment” often considerably differ from the group, 
consensus vote.
What is the implication, and what should change now: 
 Guideline panels that place a high value on adherence to the GRADE system should consider use 
of EtD framework in developing their recommendations.
 To avoid “yes” bias, guidelines developers should, in most instances, express all 
recommendations as a vote “for” instead of “against” recommendations 
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 Exploration of reasons why panel members are sometimes in agreement and sometimes not 
may inform the need for additional strategies such as more extensive training in GRADE to 
reduce variability.
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Figure 1. Participant recruitment for evaluation of clinical guidelines development process ASH panels 
Panels approached by April 7, 2017
10 panels
(137 members)
Initial demographics and decision making 
styles survey completed
8 panels
(98 members complete data, 3 members 
partial data)
Pre-meeting vote completed
4 panels (ITP, Anticoagulation, Treatment, 
Pediatric)
(58 members)
Post-meeting vote completed: 96 members
8 panels; 101 members 
104 recommendations
720 judgments on strength of 
recommendation
(9092 responses on all other domains)
Did not complete post meeting vote
(5 members)
Dropped out before initial demographics survey –
did not attend panel meetings (5 members)
Completed first demographics survey but did not 
attend panel meeting (6 members)
96/101=96% completion rate
2 panels (25 members) excluded due to technical 
glitch
10 panels
(126 members)
Effect of certainty of evidence and judgments about the balance of benefits and 
harms (in favor of intervention  over comparator)
Fig 2
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Fig 3
Agreement in judgements related to strength of recommendations between individual panel 
members and the group judgements
Fig 4
Panel
Panel 1
Panel 2
Panel 3
Panel 4
Panel 5
Panel 6
Panel 7
Total (95% CI)
Heterogeneity: Tau² = 0.06; Chi² = 150.70, df = 6 (P < 0.00001); I² = 96%
Test for overall effect: Z = 3.16 (P = 0.002)
Weight
14.9%
13.8%
14.7%
14.4%
13.1%
14.4%
14.7%
100.0%
IV, Random, 95% CI
0.03 [-0.04, 0.10]
0.38 [0.23, 0.53]
0.47 [0.39, 0.55]
0.64 [0.54, 0.74]
0.35 [0.16, 0.54]
0.01 [-0.10, 0.12]
0.21 [0.13, 0.29]
0.30 [0.11, 0.48]
Kappa Kappa
IV, Random, 95% CI
-0.5 -0.25 0 0.25 0.5
Table 1. Participant characteristics by panel#
Variable Overall
N (%)
Number of participants 101
Age, median (quartile1, quartile 3); range 48.0 (41, 56) (28 to 78)
Sex
   Male
   Female
56 (55.4)
45 (44.6)
Role
   Chair
   Methodologist
   Clinician
   Patient representatives
8 (7.9)
16 (15.8)
66 (65.4)
11 (10.9)
Panel
   Anticoagulation
   Cancer
   Heparin-Induced Thrombocytopenia
   Immune thrombocytopenia
   Pediatric
   Pregnancy
  Thrombophilia
   Treatment
13 (12.9)
15 (14.9)
11 (10.9)
16 (15.8)
15 (14.9)
10 (9.9)
7 (6.9)
14 (13.9)
Country of origin
   United States
   Canada
   Netherlands
   Italy
   United Kingdom
   Germany
   Australia
   Austria
   Argentina
   Belgium
   Denmark
   New Zealand
   Switzerland
52 (51.5)
25 (24.8)
5 (5.0)
3 (3.0)
3 (3.0)
3 (3.0)
3 (3.0)
2 (2.0)
1 (1.0)
1 (1.0)
1 (1.0)
1 (1.0)
1 (1.0)
Years of experience*, median (quartile1, quartile 3); (range) 18 (11,26) (2 to 49)
Self-reported level of experience*
   Higher than others
   About same as others
   Lower than others
46 (55.4)
32 (38.6)
5 (6.0)
How many patients with similar condition do you treat per 
month*
   None
   1 to 5
   6 to 10
   11 to 15
   More than 15
13 (16.3)
14 (17.5)
3 (3.8)
7 (8.8)
43 (53.8)
#included in the final analysis; there was no statistically significant difference between these participants 
and those that were excluded from the analysis (see Fig 1)* Questions regarding professional experience 
were only answered by clinicians
Table 2 Association Between Decision Making Factors and the Strength of Recommendations
Mixed-effect model [ordered logistic regression] 
FIXED EFFECT
Dependent Variable: Neither For/Against; Weak For/Weak Against; Strong 
For/ Strong Against
Odds Ratio (OR) with 95% Confidence Interval (CI)
Role: chair (reference category)
methodologist
patient representative
panel member
1.47(95% CI .57-3.80;p=.43
0.38(95% CI .13-1.18;p=.09)
1.07(95% CI .58-1.98;p=.83)
Vulnerable population
Yes vs. no 1.27(95% CI .81-2.00;p=.3)
Pressured to “vote” certain way
0.84(95% CI .31-2.31;p=.74)
Recused from “voting”
Yes vs. no 1.36(95% CI .92-2.03;p=.13)
Age (per decade) 1.79(95% CI 1.2 to 2.84;p=0.005)
Sex
Female vs. male 1.10(95% CI .75-1.62;p=.61)
Experience (years in management of given condition) 0.97(95% CI .926-1.00;p=.09)
Expertise (considers oneself with higher, same or low 
expertise than most other experts)
0.74(95% CI .51-1.09;p=.13)
Exposure (# of patients per month with given condition) 0.90(95% CI .770-1.06;p=.21)
Objectivism (tendency to seek empirical information) 1.29(95% CI .78-2.17;p=.34)
Tendency toward rational (analytical) thinking 0.66(95% CI .36-.1.10;p=.11)
Tendency toward experiential-intuitive thinking 0.95(95% CI .67-1.34;p=.76)
Satisficing (tendency to accept “good” enough solution) 1.13(95% CI .63-2.02;p=.68)
Maximizing(decision difficulty)-degree  difficulty experienced 
when making choices among abundant options
1.05(95% CI .78-1.41;p=.766)
Maximizing(alternative search)-tendency to expand 
resources in search for best possible solution
1.08(95% CI .81-1.43;p=.606)
Intolerance of uncertainty 0.57(95% CI .37-.86;p=0.008)
Regret of making a wrong recommendation 0.99(95% CI .98-1.02;p=.93)
 Certainty in Evidence 1.84(95% CI 1.46-2.31;p<0.0001)
Importance of patients’ values and preferences 1.48(95% CI 1.15-1.89;p=0.002)
Balance between benefits and harms 1.49(95% CI 1.31-1.70;p<0.0001)
Importance of cost and resources 1.06(95% CI .86-1.28;p=.56)
RANDOM INTERCEPTS
Panel
                                         (variance) 0.62(95% CI .19-2.05)
Participant within panel
                                        (variance) 2.18*10-34 
Table 3 Association Between Decision Making Factors and the Strength of Recommendations
Mixed-effect model [logistic regression]
FIXED EFFECT
Dependent Variable: Weak For; Strong For
Odds Ratio (OR) with 95% Confidence Interval (CI)
Role: chair (reference category)
methodologist
patient representative
panel member
0.06 (95% CI 0-.85;p=.04)
0.64(95% CI .03-12.4;p=.77)
1.15(95% CI .23-5.89;p=.87)
Vulnerable population
Yes vs. no 1.83(95% CI .56-5.91;p=.31)
Pressured to “vote” certain way 2.27(95% CI .21-24.9;p=.5)
Recused from “voting”
Yes vs. no 1.18(95% CI .4-3.45;p=.76)
Age (per decade) 2.6 (95% CI .99-7.93;p=.079)
Sex
Female vs. male 0.55(95% CI .20-1.48;p=.24)
Experience (years in management of given condition) 0.89(95% CI .76-.99;p=.047)
Expertise (consider oneself with higher, same or low 
expertise than most other experts)
1.40(95% CI .566-3.49;p=.47)
Exposure (# of patients per month with given condition) 0.89(95% CI .61-1.31;p=.57)
Objectivism (tendency to seek empirical information) 1.64(95% CI .44-6.10;p=.46)
Tendency toward rational (analytical) thinking 0.51(95% CI .15-1.76;p=.23)
Tendency toward experiential-intuitive thinking 0.89(95% CI .37-2.15;p=.79)
Satisficing 
(tendency to accept “good” enough solution
2.23(95% CI .61-8.1;p=.23)
Maximizing(decision difficulty)-degree  difficulty 
experienced when making choices among abundant 
options
2.14(95% CI .99-4.65;p=.05)
Maximizing(alternative search)-tendency to expand 
resources in search for best possible solution
0.65(95% CI .31-1.35;p=.25)
Intolerance of uncertainty 0.4(95% CI .13-1.21;p=.11)
Regret of making a wrong recommendation 0.99(95% CI .95-1.05;p=.89)
 Certainty in Evidence 3.61(95% CI 2.17-6.01;p<0.001)
Importance of patients’ values and preferences 2.33(95% CI 1.34-4.07;p=.003)
Balance between benefits and harms 18.3(95% CI 7.68-43.7;p=.000)
Importance of cost and resources 1.83(95% CI 1.25-2.67;p=.002)
RANDOM INTERCEPTS
Panel
                                         (variance) 3.14*10-32 
Participant within panel
                                        (variance) 1.00*10-33 
*when interactions with the certainty of evidence was taken into account, OR= 4.63 (95% CI 0.814 to 
26.38; p=0.084)  
Table 4 Association Between Decision Making Factors and the Strength of Recommendations
Mixed-effect model [logistic regression]
FIXED EFFECT
Dependent Variable: Weak Against; Strong Against
Odds Ratio (OR) with 95% Confidence Interval (CI)
Role: chair (reference category)
methodologist
patient representative
panel member
11.7(95% CI 1.50-91.4;p=.019)
1.28(95% CI .070-23.4;p=.87)
2.34(95% CI .558-9.83;p=.25)
Vulnerable population
Yes vs. no 3.97(95% CI 1.30-12.1;p=.015)
Pressured to “vote” certain way 0.34(95% CI .036-3.28;p=.35)
Recused from “voting”
Yes vs. no 3.34(95% CI 1.29-8.65;p=.013)*
Age (per decade) 4.8(95% CI 1.8-12.76;p=.002)
Sex
Female vs. male 0.56(95% CI .247-1.43;p=.25)
Experience (years in management of given condition) 0.87(95% CI .79-.96;p=.007)
Expertise (consider oneself with higher, same or low expertise 
than most other experts)
0.46(95% CI .18-1.15;p=.09)
Exposure (# of patients per month with given condition) 0.84(95% CI .58-1.20;p=.33)
Objectivism (tendency to seek empirical information) 1.15(95% CI .28-4.63;p=.84)
Tendency toward rational (analytical) thinking 0.215(95% CI .063-.729;p=.014)
Tendency toward experiential-intuitive thinking 1.32(95% CI .60-2.90;p=.49)
Satisficing 
(tendency to accept “good” enough solution
1.31(95% CI .36-4.72;p=.68)
Maximizing(decision difficulty)-degree  difficulty experienced 
when making choices among abundant options
1.45(95% CI .74-2.85;p=.28)
Maximizing(alternative search)-tendency to expand resources in 
search for best possible solution
1.00(95% CI .55-1.84;p=.99)
Intolerance of uncertainty 0.16(95% CI .05-.49;p=.001)
Regret of making a wrong recommendation OR=1.01(95% CI .97-1.06;p=.62)
 Certainty in Evidence OR=.98(95% CI .57-1.68;p=.94)
Importance of patients’ values and preferences 2.26(95% CI 1.32-3.87;p=.003)
Balance between benefits and harms 0.78(95% CI .52-1.23;p=.31)
Importance of cost and resources 1.01(95% CI .60-1.69;p=.97)
RANDOM INTERCEPTS
Panel
                                           (variance) 1.54(95% CI .380-6.23)
                                 Participant within panel
                                            (variance) 1.47*10-36 
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Appendix 1. GRADE Evidence to Decision Framework template 
Assessment 
 JUDGEMENT RESEARCH EVIDENCE ADDITIONAL 
CONSIDERATIONS 
PR
O
B
LE
M
 
Is the problem a priority? 
○ No 
○ Probably no 
○ Probably yes 
○ Yes 
 
○ Varies 
○ Don't know 
 
 
 
 
 
D
ES
IR
A
B
LE
 E
FF
EC
TS
 
How substantial are the desirable 
anticipated effects? 
○ Trivial 
○ Small 
○ Moderate 
○ Large 
 
○ Varies 
○ Don't know 
 
 
 
 
 
U
N
D
ES
IR
A
B
LE
 E
FF
EC
TS
 How substantial are the undesirable 
anticipated effects? 
○ Large 
○ Moderate 
○ Small 
○ Trivial 
 
○ Varies 
○ Don't know 
 
 
 
C
ER
TA
IN
TY
 O
F 
EV
ID
EN
C
E What is the overall certainty of the evidence of effects? 
○ Very low 
○ Low 
○ Moderate 
○ High 
 
○ No included studies 
 
 
 
 
 
V
A
LU
ES
 Is there important uncertainty about 
or variability in how much people 
value the main outcomes? 
 
 
 
 
○ Important uncertainty or variability 
○ Possibly important uncertainty or 
variability 
○ Probably no important uncertainty or 
variability 
○ No important uncertainty or variability 
 
B
A
LA
N
C
E 
O
F 
EF
FE
C
TS
 
Does the balance between desirable 
and undesirable effects favor the 
intervention or the comparison? 
○ Favors the comparison 
○ Probably favors the comparison 
○ Does not favor either the intervention or 
the comparison 
○ Probably favors the intervention 
○ Favors the intervention 
 
○ Varies 
○ Don't know 
 
 
 
 
 
R
ES
O
U
R
C
ES
 R
EQ
U
IR
ED
 
How large are the resource 
requirements (costs)? 
○ Large costs 
○ Moderate costs 
○ Negligible costs and savings 
○ Moderate savings 
○ Large savings 
 
○ Varies 
○ Don't know 
 
 
 
 
 
C
ER
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TY
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EN
C
E 
O
F 
R
EQ
U
IR
ED
 R
ES
O
U
R
C
ES
 
What is the certainty of the evidence 
of resource requirements (costs)? 
○ Very low 
○ Low 
○ Moderate 
○ High 
 
○ No included studies 
 
 
 
 
 
C
O
S
T 
EF
FE
C
TI
V
EN
ES
S
 
Does the cost-effectiveness of the 
intervention favor the intervention or 
the comparison? 
○ Favors the comparison 
○ Probably favors the comparison 
○ Does not favor either the intervention or 
the comparison 
○ Probably favors the intervention 
○ Favors the intervention 
 
○ Varies 
○ No included studies 
 
 
 
 
 
EQ
U
IT
Y 
What would be the impact on health 
equity? 
○ Reduced 
○ Probably reduced 
○ Probably no impact 
○ Probably increased 
○ Increased 
 
○ Varies 
○ Don't know 
 
 
 
 
 
A
C
C
EP
TA
B
IL
IT
Y 
Is the intervention acceptable to key 
stakeholders? 
○ No 
○ Probably no 
○ Probably yes 
○ Yes 
 
○ Varies 
○ Don't know 
 
 
 
 
 
FE
A
S
IB
IL
IT
Y 
Is the intervention feasible to 
implement? 
○ No 
○ Probably no 
○ Probably yes 
○ Yes 
 
○ Varies 
○ Don't know 
 
 
 
 
 
 
Summary of judgements 
 JUDGEMENT IMPLICATIONS 
PROBLEM         
DESIRABLE 
EFFECTS 
       
 
UNDESIRABLE 
EFFECTS 
       
 
CERTAINTY OF 
EVIDENCE 
       
 
VALUES         
BALANCE OF 
EFFECTS 
       
 
RESOURCES 
REQUIRED 
       
 
CERTAINTY OF 
EVIDENCE OF 
REQUIRED 
RESOURCES 
       
 
COST 
EFFECTIVENESS 
       
 
EQUITY         
ACCEPTABILITY         
FEASIBILITY         
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Informed Consent to Participate in Research  
Information to Consider Before Taking Part in this Research Study 
 
Pro # 00027571 
  
Researchers at the University of South Florida (USF) study many topics. To do this, we need the 
help of people who agree to take part in a research study. This form tells you about this research 
study. We are asking you to take part in a research study that is called:  Evaluation of the Group 
Decision-making Process of Clinical Guidelines Panels. The person who is in charge of this 
research study is Dr. Benjamin Djulbegovic. This person is called the Principal Investigator.   
This study is sponsored by: Agency for Healthcare Research (AHRQ) 
 
Purpose of the Study 
GRADE (Grading of Recommendations Assessment, Development and Evaluation) is accepted 
by more than 100 professional organizations that generate clinical practice guidelines. However, 
development of guidelines ultimately relies on the group judgment of the panel. Despite the 
importance of group judgments for issuing guidelines, little work has been done to analyze how 
this process takes place.  
The purpose of this study is to assess how group judgment process reflects the relationship 
between GRADE and other contextual factors including individual panel member expertise, 
decision-making styles, etc related to the direction and the strength of recommendations of the 
guidelines. 
Why are you being asked to take part? 
We are asking you to take part in this research study because you are a member of a panel for 
developing clinical guidelines.    
Study Procedures 
If you take part in this study, you will be asked to complete a couple of surveys in addition to 
your participation on the guideline development panel. By participating in your Clinical Practice 
Guidelines panel, you have already agreed to deliberate and issue your recommendations 
regardless of the proposed study.  For this study we ask you to help us formally analyze this 
process – by completion of the series of questionnaires- prior and during/post meeting- and 
consenting to recording the panel session discussion. 
 
At the beginning of the survey you will be asked to provide some brief demographic information 
(your area of specialty, years in practice, your age and your gender, etc). This will be followed 
by survey related to your decision-making styles. This is estimated to take about 15 minutes. 
The next part of the study will relate to your judgments regarding the formulation of guidelines 
recommendation as per GRADE process. You will be asked to evaluate the presented evidence 
and make your recommendation for or against the use of the intervention. This is expected to last 
about 15-20 minutes. 
Following the survey, you will meet with your guideline panel, where you will deliberate with 
other panel members as instructed by your Chair. As per CPG development process, you will be 
asked to cast your vote either at the end of the meeting, or one week post meeting (depending on 
your panel). One week after the meeting, we will send you a short follow-up survey (which is 
expected to take less than 5 minutes of your time) asking you for your overall impression of the 
guidelines development process. 
We will record discussion that occurs during the meeting, which we will then subject to 
qualitative analysis to identify any new themes of importance for guidelines development that 
may have not been previously included in the GRADE system. Although by agreeing to 
participate in the panel, you expressed your willingness to voice your opinion to help improve 
CPG process, we will deidentify all data prior to analysis. Therefore, there is no way that any 
particular opinion will be linked back to any individual participant.  
Please note that once you complete all answers, the random code will be generated related to 
your participation and all your identifying information will be erased. Hence, no one will be able 
to link your answers to you. That is, the surveys will remain anonymous. 
Alternatives / Voluntary Participation / Withdrawal  
You have the alternative to choose not to participate in this research study. 
You should only take part in this study if you want to volunteer; you are free to participate in this 
research or withdraw at any time.  There will be no penalty or loss of benefits you are entitled to 
receive if you stop taking part in this study. Your decision to not partake in this study will not 
affect your participation as a member of the CPG panel. 
Benefits and Risks 
You will receive no benefit from this study.  
This research is considered to be minimal risk. 
Compensation  
We will not pay you for the time you volunteer while being in this study.   
Privacy and Confidentiality 
We must keep your study records as confidential as possible. It is possible, although unlikely, 
that unauthorized individuals could gain access to your responses because you are responding 
online.  
 
Certain people may need to see your study records. By law, anyone who looks at your records 
must keep them completely confidential. The only people who will be allowed to see these 
records are: the Principal Investigator and research team data analyst, The University of South 
Florida Institutional Review Board (IRB) and government offices such as, The Department of 
Health and Human Services (DHHS).   
• It is possible, although unlikely, that unauthorized individuals could gain access to your 
responses.  Confidentiality will be maintained to the degree permitted by the technology 
used.  No guarantees can be made regarding the interception of data sent via the Internet.  
However, your participation in this online survey involves risks similar to a person’s 
everyday use of the Internet.  If you complete and submit an anonymous survey and later 
request your data be withdrawn, this may or may not be possible as the researcher may be 
unable to extract anonymous data from the database. 
Contact Information 
 
If you have any questions about your rights as a research participant, please contact the USF IRB 
at (813) 974-5638 or contact by email at RSCH-IRB@usf.edu. If you have questions regarding 
the research, please contact the Principal Investigator at Dr. Benjamin Djulbegovic at USF 
Health, phone: (813) 396-2349, email: bdjulbeg@health.usf.edu. 
 
We may publish what we learn from this study. If we do, we will not let anyone know your 
name. We will not publish anything else that would let people know who you are. You can print 
a copy of this consent form for your records.  
I freely give my consent to take part in this study.  I understand that by proceeding with this 
survey that I am agreeing to take part in research and I am 18 years of age or older. 
 
[ https://usf.qualtrics.com] 
  
A) Part I: Baseline survey to be administered to all participants before the guideline 
panel meets 
 
Thank you for choosing to participate in our study. Below is a baseline survey that includes 
several demographic questions, a set of standard scales that have been validated in prior 
studies used to evaluate decision making style1-8, a GRADE evaluation tool, and your 
recommendations. The survey is expected to take approximately 15 to 20 minutes to complete. 
 
Demographics 
 
 
What is your primary role on the current panel (please select only one) 
                                                               
 
 
 
Prior to this panel, have you previously participated in the development of guidelines? 
 
 Yes  No 
 
If you answered ‘yes’, how many guidelines have you participated in:  
 
In what capacity did you participate in previous guidelines? (please select all that apply) 
 
 Panel member  Methodologist  Panel Chair   Other:  
 
 
 
What is your formal education (e.g. MD, RN, MSc, MPH, PhD, etc.)?  
 
 
 
Do you have formal training in health research methodology/epidemiology/biostatistics? 
 Never completed formal training 
 Completed some formal training but do not have graduate degree 
 Earned MSc degree 
 Earned PhD degree 
 
 
Indicate your field of work (please select only one) 
                                                               
 
 
Please specify 'other' areas of expertise:   
 
 
 
 
 
How many years of experience do you have in your field?   
 
 
 
 
If you are a clinical expert, compared to other people you know in your field, how would you rate 
your level of expertise regarding the recommendations you are most knowledgeable about? 
 
 Higher than others 
 
About the same as 
others 
 Lower than others 
 
 
If you are a clinical expert, how many patients do you see per month that match the population 
affected by the guideline you have the most expertise in? 
 
 None 
 1 to 5 
 6 to 10 
 11 to 15 
 More than 15 
 
 
 
 
What is your age?    
 
 
 
 
What is your gender? 
 Male  Female 
 
 
 
 
Do you have any financial conflict of interest with respect to the guideline recommendations? 
  Yes  No 
 
If you answered ‘yes’, please briefly explain below: 
 
 
 
 
 
 
Do you have any intellectual conflict of interest with respect to the guideline recommendations? 
 
 Yes  No 
 
If you answered ‘yes’, please briefly explain below: 
 
 
 
 
 
Do you have any institutional conflict of interest with respect to the guideline recommendations? 
 
 Yes  No 
 
If you answered ‘yes’, please briefly explain below: 
 
 
 
 
Do you believe that these guidelines have particular social implications which may affect one or 
more vulnerable populations [e.g. women, children, racial and ethnic minorities, populations with 
special health care needs (chronic illness, disabilities, and end of life), the elderly, low-income, 
inner-city, and rural populations]? 
 Yes  No 
 
If you answered ‘yes’, please briefly explain below: 
 
 
 
 
 
 
Do you feel that you are expected to conform or inappropriately pressured to vote (issue 
recommendation) in a particular way?  
 
 Yes  No 
 
If you answered ‘yes’, please indicate where the pressure is coming from: 
 Peers 
 Politicians 
 Regulators 
 Government 
 Insurance  
 Society at large 
 Other, please briefly explain:  
  
 
Assessment of individual differences (or, traits) in decision-making 
 
All scales and items within scales will be randomly presented to control for order effects. 
 
Objectivism Scale. 4 (The scale is identified here for the reviewers' convenience. This label will 
not be presented to participants.) 
 
Below are several statements that describe how various people make decisions in general. 
Read each statement carefully and think about the extent to which the statement describes you. 
Use the following rating scale to indicate your responses. 
  
0 1 2 3 4 
Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
 
1. ____ I seek as much information as possible before making decisions. 
 
2. ____ I think the answers to most questions in life can be found through careful, objective 
             analysis of the situation. 
 
3. ____ I do not like to be too objective in the way I look at things. 
 
4. ____ Trying to be highly objective and rational does not improve my ability to make good 
             decisions. 
 
5. ____ I see myself as a rational and objective person. 
 
6. ____ After I make a decision, it is often difficult for me to give logical reasons for it. 
 
7. ____ I gather as much information as possible before making decisions. 
 
8. ____ The solution to many problems in life can not be found through an intellectual 
              examination of the facts. 
 
9. ____ I try to employ a cool-headed, objective approach when making decisions about my life. 
 
10. ____ I am only confident of decisions that are made after careful analysis of all available 
               information. 
 
11. ____ I tend not to be particularly objective or logical in my approach to life. 
  
Rational-Experiential Inventory. 5 (The scale is identified here for the reviewers' convenience. 
This label will not be presented to participants.) 
 
Below are several statements that describe how various people make decisions in general. 
Read each statement carefully and think about the extent to which the statement describes you. 
Use the following rating scale to indicate your responses. 
 
0 1 2 3 4 
Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
 
  1. _____ I would not want to depend on anyone who described himself or herself as intuitive. 
  2. _____ My snap judgments are probably not as good as most people's. 
  3. _____ I tend to use my heart as a guide for my actions. 
  4. _____ I can usually feel when a person is right or wrong, even if I can't explain how I know. 
  5. _____ I suspect my hunches are inaccurate as often as they are accurate. 
  6. _____ I try to avoid situations that require thinking in depth about something. 
  7. _____ I'm not that good at figuring out complicated problems. 
  8. _____ When it comes to trusting people, I can usually rely on my gut feelings. 
  9. _____ I enjoy intellectual challenges. 
10. _____ I am not very good at solving problems that require careful logical analysis. 
11. _____ I don't like to have to do a lot of thinking. 
12. _____ I often go by my instincts when deciding on a course of action. 
13. _____ I trust my initial feelings about people. 
14. _____ If I were to rely on my gut feelings, I would often make mistakes. 
15. _____ I don't like situations in which I have to rely on intuition. 
16. _____ Knowing the answer without having to understand the reasoning behind it is good 
                 enough for me. 
17. _____ I don't reason well under pressure. 
18. _____ I am much better at figuring things out logically than most people. 
19. _____ I have a logical mind. 
20. _____ I enjoy thinking in abstract terms. 
21. _____ Thinking hard and for a long time about something gives me little satisfaction. 
22. _____ I think there are times when one should rely on one's intuition. 
23. _____ I think it is foolish to make important decisions based on feelings.  
Rational-Experiential Inventory (continued). (The scale is identified here for the reviewers' 
convenience. This label will not be presented to participants.) 
 
0 1 2 3 4 
Not at all 
characteristic 
of me 
Lightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
 
   
24. _____ I don't think it is a good idea to rely on one's intuition for important decisions. 
25. _____ I generally don't depend on my feelings to help me make decisions. 
26. _____ I hardly ever go wrong when I listen to my deepest gut feelings to find an answer. 
27. _____ I have no problem thinking things through carefully. 
28. _____ Using logic usually works well for me in figuring out problems in my life. 
29. _____ I usually have clear, explainable reasons for my decisions. 
30. _____ Learning new ways to think would be very appealing to me. 
31. _____ I like to rely on my intuitive impressions. 
32. _____ I don't have a very good sense of intuition. 
33. _____ Using my gut feelings usually works well for me in figuring out problems in my life. 
34. _____ I believe in trusting my hunches. 
35. _____ Intuition can be a very useful way to solve problems. 
36. _____ I enjoy solving problems that require hard thinking. 
37. _____ Thinking is not my idea of an enjoyable activity. 
38. _____ I am not a very analytical thinker. 
39. _____ Reasoning things out carefully is not one of my strong points. 
40. _____ I prefer complex problems to simple problems. 
  
Intolerance for Ambiguity Scale. 2 (The scale is identified here for the reviewers' convenience. 
This label will not be presented to participants.) 
 
Below are several general statements regarding how people perceive and think about the world 
around them. Please read each statement carefully. Indicate the extent to which you agree or 
disagree with each statement using the following rating scale: 
 
      
1 2 3 4 5 6 
Strongly 
disagree Disagree 
Slightly 
disagree 
Slightly 
agree Agree 
Strongly 
agree 
 
 
1. _____ An expert who doesn't come up with a definite answer probably doesn't know very 
               much. 
2. _____ Teachers or supervisors who hand out vague assignments give a chance for one to 
        show initiative and originality. 
3. _____ People who fit their lives to a schedule probably miss most of the joy of living. 
4. _____ Often the most interesting and stimulating people are those who don't mind being 
       different and original. 
5. _____ It is more fun to tackle a complicated problem than to solve a simple one. 
6. _____ In the long run it is possible to get more done by tackling small, simple problems 
        rather than large and complicated ones. 
 7. _____ A good job is one where what is to be done and how it is to be done are always clear. 
 8. _____ A person who leads an even, regular life in which few surprises or unexpected 
                happenings arise, really has a lot to be grateful for. 
 9. _____ What we are used to is always preferable to what is unfamiliar to us. 
10. _____ People who insist upon a "yes" or "no" answer just don't know how complicated 
                 things really are. 
11. _____ There is really no such thing as a problem that can't be solved. 
12. _____ Many of our most important decisions are based upon insufficient information. 
13. _____ I like parties where I know most of the people more than ones where all or most of 
                 the people are complete strangers. 
14. _____ I would like to live in a foreign country for a while. 
15. _____ The sooner we all acquire similar values and ideals the better. 
16. _____ A good teacher is one who makes you wonder about your own way of looking at 
                 things. 
 
Decision Making Tendency Inventory9 (The scale is identified here for the reviewers' 
convenience. This label will not be presented to participants.) 
 
Below are several statements that describe how various people make decisions in general. 
Read each statement carefully and think about the extent to which the statement describes you. 
Use the following rating scale to indicate your responses. 
 
0 1 2 3 4 
Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
 
 
 
Satisficing  
1. _____ In every area, I try to achieve results that are satisfactory for me  
2. _____ In studying or working, I tend to choose solutions that guarantee satisfactory results for 
me 
3. _____ When I make decisions, I spend the time required to choose an alternative that is 
satisfactory for me 
4. _____ In studying or working, I spend the time required to choose solutions that meet my needs 
5. _____ If I am happy with my work, I do not seek better opportunities 
6. _____ In choosing between alternatives, I stop at the first that works for me 
7.  _____ I do not ask for more than what satisfies me 
8. _____ When I watch TV or listen to the radio, I tend to follow the first program that I find 
interesting 
 
 
  
Maximizing Tendency Inventory10 (The scale is identified here for the reviewers' convenience. 
This label will not be presented to participants.) 
 
Below are several statements that describe how various people make decisions in general. 
Read each statement carefully and think about the extent to which the statement describes you. 
Use the following rating scale to indicate your responses. 
 
0 1 2 3 4 
Not at all 
characteristic 
of me 
Slightly 
characteristic 
of me 
Moderately 
characteristic 
of me 
Very 
characteristic 
of me 
Extremely 
characteristic 
of me 
 
 
1. _____ No matter what I do, I have the highest standards for myself. 
2. _____ I never settle for second best. 
3. _____ No matter what it takes, I always try to choose the best thing. 
4. _____ I don’t like having to settle for “good enough.” 
5. _____ I am a maximizer. 
6. _____ I will wait for the best option, no matter how long it takes. 
7. _____ I never settle. 
 
Maximization Inventory11 (The scale is identified here for the reviewers' convenience. This 
label will not be presented to participants.) 
 
Below are several statements describing how people think and feel about decision making. Please read 
each statement carefully. Indicate the extent to which you agree or disagree with each statement using 
the following rating scale: 
 
1 2 3 4 5 6 
Strongly 
disagree Disagree 
Slightly 
disagree 
Slightly 
agree Agree 
Strongly 
agree 
 
  1. ____ I usually try to find a couple of good options and then choose between them. 
  2. ____ I usually have a hard time making even simple decisions. 
  3. ____ I can’t come to a decision unless I have carefully considered all of my options. 
  4. ____ At some point you need to make a decision about things. 
  5. ____ I am usually worried about making a wrong decision. 
  6. ____ I take time to read the whole menu when dining out. 
  7. ____ In life I try to make the most of whatever path I take. 
  8. ____ I often wonder why decisions can’t be more easy. 
  9. ____ I will continue shopping for an item until it reaches all of my criteria.  
10. ____ There are usually several good options in a decision situation. 
11. ____ I often put off making a difficult decision until a deadline. 
12. ____ I usually continue to search for an item until it reaches my expectations. 
13. ____ I try to gain plenty of information before I make a decision, but then I go ahead and make it. 
14. ____ I often experience buyer’s remorse.  
15. ____ When shopping, I plan on spending a lot of time looking for something. 
16. ____ Good things can happen even when things don’t go right at first. 
17. ____ I often think about changing my mind after I have already made my decision. 
18. ____ When shopping, if I can’t find exactly what I’m looking for, I will continue to search for it. 
19. ____ I can’t possibly know everything before making a decision. 
20. ____ The hardest part of making a decision is knowing I will have to leave the item I didn’t choose 
                behind. 
21. ____ I find myself going to many different stores before finding the thing I want. 
22. ____ I do not agonize over decisions. 
23. ____ I just won’t make a decision until I am comfortable with the process. 
24. ____ All decisions have pros and cons. 
25. ____ I often change my mind several times before making a decision. 
26. ____ When shopping for something, I don’t mind spending several hours looking for it. 
27. ____ I know that if I make a mistake in a decision that I can go “back to the drawing board.” 
28. ____ It’s hard for me to choose between two good alternatives. 
29. ____ I take the time to consider all alternatives before making a decision. 
30. ____ I accept that life often has uncertainty. 
31. ____ Sometimes I procrastinate in deciding even if I have a good idea of what decision I will make. 
32. ____ When I see something that I want, I always try to find the best deal before purchasing it. 
33. ____ I find myself often faced with difficult decisions. 
34. ____ If a store doesn’t have exactly what I’m shopping for, then I will go somewhere else. 
  
Anticipated Regret Scale 3,6,7 
 
Read each statement below carefully and think about the extent to which the statement 
describes your attitude. Use the scale below to indicate your responses or enter a number form 
0 (no regret) to 100 (maximum regret). 
 
When you cast your  "vote" as a STRONG recommendation FOR a health intervention how 
much regret would you feel if it turned out to be unnecessary and possibly harmful (which will 
lead to more undesirable than desirable consequences)?  
 
 
 
 
Enter your level of regret:  
 
When you cast your  "vote" as a STRONG recommendation AGAINST a health intervention how 
much regret would you feel if you failed to recommend a health intervention that could improve 
patient outcomes (which will fail to lead to more desirable than undesirable 
consequences)? 
 
 
 
 
Enter your level of regret:  
 
When you cast your  "vote" as a WEAK recommendation FOR a health intervention how much 
regret would you feel if it turn out to be unnecessary and possibly harmful (which will lead to 
more undesirable than desirable consequences)? 
 
 
 
 
Enter your level of regret:  
Maximum 
regret 
No 
regret 
0 100 
Maximum 
regret 
No 
regret 
0 100 
Maximum 
regret 
No 
regret 
0 100 
 When you cast your  "vote" as the WEAK recommendation AGAINST a health intervention how 
much regret would you feel if you failed to recommend a health intervention that could improve 
patient outcomes (which will fail to lead to more desirable than undesirable 
consequences)? 
 
 
 
 
Enter your level of regret:  
  
Maximum 
regret 
No 
regret 
0 100 
A) Part II: GRADE data presentation (BEFORE the panel meeting) 
You are about to be asked to make a recommendation for or against the use of intervention 
___________ for condition ____________. Before making your recommendation please review 
the summary assessment of key GRADE domains already provided for you. If you disagree with 
any domain summary, please indicate your opinion below each statement. 
 
1) Is the problem a 
priority? 
 
 No 
 Probably no 
 Probably yes 
 Yes 
 Varies 
 Don’t know 
If you disagree with the assessment above, please indicate your perceived assessment of problem 
priority:  
 
 
2) How substantial are the 
desirable anticipated 
effects? 
 
 Trivial 
 Small 
 Moderate 
 Large 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of desirable 
anticipated effects:  
 
 
 
3) How substantial are the 
undesirable anticipated 
effects? 
 
 
 Large 
 Moderate 
 Small 
 Trivial 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of undesirable 
anticipated effects:  
 
 
 
 
 
 
 
 Very low 
4) What is the overall 
certainty (quality) of the 
evidence of effects? 
 
 
 
 Low 
 Moderate 
 High 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of certainty 
(quality) of the evidence of effects:  
 
 
 
 
 
5) Is there important 
uncertainty about or 
variability in how much 
people value the main 
outcomes? 
 Important uncertainty or variability 
 Possibly important uncertainty or variability 
 Probably no important uncertainty or variability 
 No important uncertainty or variability 
 
If you disagree with the assessment above, please indicate your perceived assessment of how much 
people value the main outcomes:  
 
 
 
 
 
 
6) Does the balance 
between desirable and 
undesirable effects favor 
the intervention or the 
comparison? 
 
 Favors the comparison 
 Probably favors the comparison 
 
Does not favor either the intervention or the 
comparison 
 Probably favors the intervention 
 Favors the intervention 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of balance 
between desirable and undesirable effects:  
 
 
 
 
 
7) How large are 
the resource 
requirements 
(costs)? 
 
 Large costs 
 Moderate costs 
 
Negligible costs and 
savings 
 Moderate savings 
  Large savings 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of the resource 
requirements (costs):  
 
 
 
8) What would 
be the impact 
on health 
equity? 
 
 
 Reduced 
 Probably reduced 
 Probably no impact 
 Probably increased 
 Increased 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of the impact on 
health equity:  
 
 
 
9) Is the 
intervention 
acceptable to key 
stakeholders? 
 
 
 No 
 Probably no 
 Probably yes 
 Yes 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of the 
intervention’s acceptability to stakeholders:  
 
 
 
 10) Is the intervention 
feasible to implement? 
 
 
 
 No 
 Probably no 
 Probably yes 
 Yes 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of feasibility of 
the intervention’s implementation:  
 
 
 
  
Recommendation vote 
Please indicate your recommendation related to the use of intervention ___________ for 
condition ____________. 
 
 
 
 
 
B) Participants of guideline panels meet to discuss recommendations. The deliberations 
are recorded. [Details related to specific guideline recommendations will also be 
recorded in the PICO (patients, interventions, comparators, outcomes) 
format]. 1Immediately during, or within a week following the guideline panel 
meeting, the participants are asked to complete the following survey. 
 
  
                                                            
1 This will be panel dependent; some panels will use GDP software, so all “votes” will be recorded during the 
meeting. 
 
I STRONGLY recommend FOR using intervention ___________ 
for condition ____________. 
 
I WEAKLY recommend FOR using intervention ___________ for 
condition ____________. 
 
I WEAKLY recommend AGAINST using intervention ___________ 
for condition ____________. 
 
I STRONGLY recommend AGAINST intervention ___________ for 
condition ____________. 
GRADE data presentation (DURING/AFTER the panel meeting) 
You are about to be asked to make a recommendation for or against the use of intervention 
___________ for condition ____________. Before making your recommendation please review 
the summary assessment of key GRADE domains already provided for you. If you disagree with 
any domain summary, please indicate your opinion below each statement. 
 
1) Is the problem a 
priority? 
 
 No 
 Probably no 
 Probably yes 
 Yes 
 Varies 
 Don’t know 
If you disagree with the assessment above, please indicate your perceived assessment of problem 
priority:  
 
 
2) How substantial are the 
desirable anticipated 
effects? 
 
 Trivial 
 Small 
 Moderate 
 Large 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of desirable 
anticipated effects:  
 
 
 
3) How substantial are the 
undesirable anticipated 
effects? 
 
 
 Large 
 Moderate 
 Small 
 Trivial 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of undesirable 
anticipated effects:  
 
 
 
 
 
 
 
 Very low 
4) What is the overall 
certainty (quality) of the 
evidence of effects? 
 
 
 
 Low 
 Moderate 
 High 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of certainty 
(quality) of the evidence of effects:  
 
 
 
 
 
5) Is there important 
uncertainty about or 
variability in how much 
people value the main 
outcomes? 
 Important uncertainty or variability 
 Possibly important uncertainty or variability 
 Probably no important uncertainty or variability 
 No important uncertainty or variability 
 
If you disagree with the assessment above, please indicate your perceived assessment of how much 
people value the main outcomes:  
 
 
 
 
 
 
6) Does the balance 
between desirable and 
undesirable effects favor 
the intervention or the 
comparison? 
 
 Favors the comparison 
 Probably favors the comparison 
 
Does not favor either the intervention or the 
comparison 
 Probably favors the intervention 
 Favors the intervention 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of balance 
between desirable and undesirable effects:  
 
 
 
 
 
7) How large are 
the resource 
requirements 
(costs)? 
 
 Large costs 
 Moderate costs 
 
Negligible costs and 
savings 
 Moderate savings 
  Large savings 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of the resource 
requirements (costs):  
 
 
8) What would 
be the impact 
on health 
equity? 
 
 
 Reduced 
 Probably reduced 
 Probably no impact 
 Probably increased 
 Increased 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of the impact on 
health equity:  
 
 
 
9) Is the 
intervention 
acceptable to key 
stakeholders? 
 
 
 No 
 Probably no 
 Probably yes 
 Yes 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of the 
intervention’s acceptability to stakeholders:  
 
 
 
 No 
10) Is the intervention 
feasible to implement? 
 
 
 
 Probably no 
 Probably yes 
 Yes 
 Varies 
 Don’t know 
 
If you disagree with the assessment above, please indicate your perceived assessment of feasibility of 
the intervention’s implementation:  
 
 
  
Recommendation vote 
Please indicate your recommendation related to the use of intervention ___________ for 
condition ____________. 
 
 
 
  
 
I STRONGLY recommend FOR using intervention ___________ 
for condition ____________. 
 
I WEAKLY recommend FOR using intervention ___________ for 
condition ____________. 
 
I WEAKLY recommend AGAINST using intervention ___________ 
for condition ____________. 
 
I STRONGLY recommend AGAINST intervention ___________ for 
condition ____________. 
C) Follow-up survey to be administered to all participants within 1 week of guideline 
panel meeting 
Thank you for participating in our study. Below is a brief follow-up related to your participation in 
development of clinical practice guidelines and an assessment of how you feel about your decision. The 
survey is expected to take less than 5 minutes to complete but you can take as long as you wish to 
answer questions the asked in the survey. 
 
Post Decisional Regret Scale 
1. Brehaut scale 1 
Please reflect on the final vote that your panel made for all recommendations for or against a health 
intervention. Please indicate how strongly you agree or disagree with the statements below with respect 
to majority (>80%) of your recommendations by using the following rating scale: 
1 2 3 4 5 
Strongly 
agree Agree 
Neither 
agree nor 
disagree 
Disagree Strongly disagree 
  1. ____ It was the right decision (recommendation). 
  2. ____ I regret the choices (recommendations) that were made. 
  3. ____ I would go (vote) for the same choices (recommendations) if I had to do it over again. 
  4. ____ The choices (recommendations) will do a lot of harm. 
  5. ____ The decisions (recommendations) were wise. 
 
If you believe that you should have made some recommendations differently, please briefly 
explain below: 
 
 
2. Do you feel that you were expected to conform or were inappropriately 
pressured to vote (issue recommendation) in a particular way?  
 
 Yes  No 
 
If you answered ‘yes’, please indicate where the pressure came from: 
 Peers 
 Politicians 
 Regulators 
 Government 
 Insurance  
 Society at large 
 Other, please briefly explain:  
 
  
3. Did you feel that discussion/beliefs of a single individual had disproportionate 
influence on the guidelines development process? 
 Yes  No 
If you answered ‘yes’, please briefly explain below: 
 
4. Your overall comments 
Please provide us with any other thoughts you have related to the guidelines recommendations process 
in which you participated. We would appreciate receiving both “positive” and “negative” comments. 
 
 
 
 
 
D) Closing questions to be completed by the guideline chair after peer review 
process is completed 
 
1. Have guideline recommendations changed as a result of the peer-review 
process? 
 Yes  No 
If you answered ‘yes’, please indicate how many recommendations changed and comment on what 
changes occurred (e.g. the quality of evidence was reassessed, the strength of recommendation was 
modified, etc.) 
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